Sun Pharma to sell Ranbaxy's 2 CNS divisions to Strides for Rs 165 crore
Sun Pharmaceutical Industries Ltd is selling erstwhile Ranbaxy's two divisions in central nervous system (CNS) segment in India to Strides Arcolab for Rs 165 crore.
Sep 19, 2015, 15:13 PM IST